IMTX Latest Press Releases

-- August 25, 2026 --

Immatics Announces $150 Million Underwritten Offering Globe Newswire 7:00 AM

-- August 18, 2026 --

Immatics Announces Second Quarter 2026 Financial Results and Business Update Globe Newswire 7:00 AM

-- July 17, 2026 --

Immatics Announces Upcoming Presentations Across Its PRAME Franchise at ESMO Congress 2026 Globe Newswire 10:24 AM

-- June 1, 2026 --

Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting Globe Newswire 8:00 AM

-- May 31, 2026 --

Immatics Presents Data on IMA401 MAGEA4/8 Bispecific at 2026 ASCO Annual Meeting with Simultaneous Publication in Nature Medicine Supporting Development of IMA401/IMA402 Combination in Lung Cancer Globe Newswire 9:00 AM

-- May 30, 2026 --

Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes